Eri Okada

466 total citations
28 papers, 245 citations indexed

About

Eri Okada is a scholar working on Molecular Biology, Rheumatology and Genetics. According to data from OpenAlex, Eri Okada has authored 28 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Rheumatology and 9 papers in Genetics. Recurrent topics in Eri Okada's work include Osteoarthritis Treatment and Mechanisms (9 papers), Knee injuries and reconstruction techniques (6 papers) and Renal and related cancers (6 papers). Eri Okada is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (9 papers), Knee injuries and reconstruction techniques (6 papers) and Renal and related cancers (6 papers). Eri Okada collaborates with scholars based in Japan and Indonesia. Eri Okada's co-authors include Masato Sato, Eriko Toyoda, Takumi Takahashi, Masahiko Watanabe, Miki Maehara, Tomohiko Yamamura, Kandai Nozu, Tomoko Horinouchi, Nana Sakakibara and Yuya Aoto and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Cell Science.

In The Last Decade

Eri Okada

26 papers receiving 243 citations

Peers

Eri Okada
Vera Kufner Croatia
Allen Zinkle United States
Olfa Ghali France
Masakazu Toya United States
A.B. Tran United States
Vera Kufner Croatia
Eri Okada
Citations per year, relative to Eri Okada Eri Okada (= 1×) peers Vera Kufner

Countries citing papers authored by Eri Okada

Since Specialization
Citations

This map shows the geographic impact of Eri Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Okada more than expected).

Fields of papers citing papers by Eri Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eri Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Okada. The network helps show where Eri Okada may publish in the future.

Co-authorship network of co-authors of Eri Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Eri Okada. A scholar is included among the top collaborators of Eri Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eri Okada. Eri Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Yu, China Nagano, Eri Okada, et al.. (2025). Phenotype and genotype of autosomal dominant tubulointerstitial kidney disease in a Japanese cohort. Clinical and Experimental Nephrology. 29(6). 788–796. 1 indexed citations
2.
Rossanti, Rini, Eri Okada, Ryota Suzuki, et al.. (2025). Comprehensive Splice Pattern Analysis for Previously Reported OCRL Splicing Variants and Their Phenotypic Contributions. Kidney International Reports. 10(5). 1509–1517. 1 indexed citations
3.
Suzuki, Ryota, Nana Sakakibara, Yu Tanaka, et al.. (2024). Genotype and X-chromosome inactivation are associated with disease severity in females with X-linked Alport syndrome. Nephrology Dialysis Transplantation. 40(4). 688–695. 1 indexed citations
4.
Kondo, Atsushi, Yu Tanaka, Ryota Suzuki, et al.. (2024). Evaluation of pathogenicity of WT1 intron variants by in vitro splicing analysis. Clinical and Experimental Nephrology. 28(11). 1075–1081.
5.
Suzuki, Ryota, Yu Tanaka, Eri Okada, et al.. (2023). Systematic Review of Clinical Characteristics and Genotype-Phenotype Correlation in LAMB2-Associated Disease. Kidney International Reports. 8(9). 1811–1821. 4 indexed citations
6.
Okada, Eri, Tomoko Horinouchi, Tomohiko Yamamura, et al.. (2023). All reported non-canonical splice site variants in GLA cause aberrant splicing. Clinical and Experimental Nephrology. 27(9). 737–746. 5 indexed citations
7.
Okada, Eri, Yuya Aoto, Tomoko Horinouchi, et al.. (2022). Aberrant splicing caused by exonic single nucleotide variants positioned 2nd or 3rd to the last nucleotide in the COL4A5 gene. Clinical and Experimental Nephrology. 27(3). 218–226. 7 indexed citations
8.
Ichikawa, Daisuke, et al.. (2021). Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy. PLoS ONE. 16(5). e0251294–e0251294. 2 indexed citations
9.
Ishiko, Shinya, Naoya Morisada, Atsushi Kondo, et al.. (2021). Clinical features of autosomal recessive polycystic kidney disease in the Japanese population and analysis of splicing in PKHD1 gene for determination of phenotypes. Clinical and Experimental Nephrology. 26(2). 140–153. 7 indexed citations
10.
Toyoda, Eriko, Takumi Takahashi, Miki Maehara, et al.. (2021). Development of Injectable Polydactyly-Derived Chondrocyte Sheets. International Journal of Molecular Sciences. 22(6). 3198–3198. 4 indexed citations
11.
Aoto, Yuya, Tomoko Horinouchi, Tomohiko Yamamura, et al.. (2021). Last Nucleotide Substitutions of COL4A5 Exons Cause Aberrant Splicing. Kidney International Reports. 7(1). 108–116. 19 indexed citations
12.
Yamamura, Tomohiko, China Nagano, Tomoko Horinouchi, et al.. (2021). Systematic Review of Genotype-Phenotype Correlations in Frasier Syndrome. Kidney International Reports. 6(10). 2585–2593. 16 indexed citations
13.
Kondo, Atsushi, China Nagano, Shinya Ishiko, et al.. (2021). Examination of the predicted prevalence of Gitelman syndrome by ethnicity based on genome databases. Scientific Reports. 11(1). 16099–16099. 20 indexed citations
14.
Rossanti, Rini, Kandai Nozu, Atsushi Fukunaga, et al.. (2021). X-chromosome inactivation patterns in females with Fabry disease examined by both ultra-deep RNA sequencing and methylation-dependent assay. Clinical and Experimental Nephrology. 25(11). 1224–1230. 11 indexed citations
15.
Kawaguchi, Takehiko, Takayuki Hamano, Ikuto Masakane, et al.. (2021). Association of kidney transplantation with mortality on hemodialysis after graft failure. Journal of Nephrology. 34(2). 521–530.
16.
Nagano, China, Yutaka Takaoka, Koichi Kamei, et al.. (2021). Genotype-Phenotype Correlation in WT1 Exon 8 to 9 Missense Variants. Kidney International Reports. 6(8). 2114–2121. 13 indexed citations
17.
Sato, Masato, Miki Maehara, Eriko Toyoda, et al.. (2020). Characteristics of autologous protein solution and leucocyte-poor platelet-rich plasma for the treatment of osteoarthritis of the knee. Scientific Reports. 10(1). 10572–10572. 12 indexed citations
18.
Toyoda, Eriko, Masato Sato, Takumi Takahashi, et al.. (2019). Transcriptomic and Proteomic Analyses Reveal the Potential Mode of Action of Chondrocyte Sheets in Hyaline Cartilage Regeneration. International Journal of Molecular Sciences. 21(1). 149–149. 19 indexed citations
19.
Maehara, Miki, Masato Sato, Eriko Toyoda, et al.. (2017). Characterization of polydactyly-derived chondrocyte sheets versus adult chondrocyte sheets for articular cartilage repair. Inflammation and Regeneration. 37(1). 22–22. 25 indexed citations
20.
Sato, Masato, Akihiro Umezawa, Genya Mitani, et al.. (2015). Assessment of the Safety of Chondrocyte Sheet Implantation for Cartilage Regeneration. Tissue Engineering Part C Methods. 22(1). 59–68. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026